The DOI matches its Crossref record; the references it cites are not checked yet.
Inhibition of antigen presentation during AAV gene therapy using virus peptides
Open accessAbstract
The clinical trial using adeno-associated virus (AAV) vector delivery of mini-dystrophin in patients with Duchenne Muscular Dystrophy (DMD) demonstrated a cytotoxic lymphocyte (CTL) response targeting the transgene product. These mini-dystrophin-specific T-cells have the potential to clear all transduced muscle, presenting the general gene therapy concern of overcoming the CTL response to foreign proteins that provide therapeutic benefit. In this study, we exploited a natural immunosuppression strategy employed by some viruses that results in CTL evasion only in transduced cells. After transfection of the plasmids encoding viral peptides and ovalbumin, which includes the immune-domain epitope SIINFEKL, several viral small peptides (ICP47 and US6) inhibited the SIINFEKL peptide presentation. A single AAV vector genome that consisted of either transgene AAT fused with SIINFEKL epitope and, separately, ICP47 expressed from different promoters or a single fusion protein with ICP47 linked by a furin cleavage peptide (AATOVA-ICP47) decreased antigen presentation. Compared with AAV/AATOVA in which decreased AAT expression was observed at late time points, persistent transgene expression was obtained after systemic administration of AAV/AATOVA-ICP47 vectors in mice. We extended this strategy to DMD gene therapy. After administration of AAV vector encoding human mini-dystrophin fusion protein with ICP47 into mdx mice, a lower mini-dystrophin-specific CTL response was induced. Importantly, the ICP47 fusion to mini-dystrophin inhibited CTLs mediated cytotoxicity. Although demonstrated herein using AAT and mini-dystrophin transgenes in an AAV context, the collective results have implications for all gene therapy applications resulting in foreign peptides by immune suppression in only genetically modified cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Expressing ICP47 from the AAV genome has been shown to reduce CTL responses in mice (176).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [176]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 94 · Cited by 17
Metadata
- Authors
- Shao, W., Chen, X., Samulski, R. J., Hirsch, M. L., & Li, C.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Li, Chengwen
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-12-19
- Volume
- 27
- Issue
- 4
- Pages
- 601-613
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC5886241
- OpenAlex
- W2775943518
- Cited by
- 17
- References
- 94
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 2
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA16086, R01AI117408, R01HL125749, R01AI072176, R01AR064369)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus vectors, ICP47, mini-dystrophin, Duchenne muscular dystrophy, SIINFEKL epitope, persistent transgene expression, cytotoxic T lymphocytes
- MeSH terms
- Dependovirus, Animals, Female, Male, Peptides, Spleen, T-Lymphocytes, Viral Proteins, Genetic Therapy, Antigen Presentation, Muscle, Skeletal, Muscular Dystrophy, Duchenne, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of antigen presentation during AAV gene therapy using virus peptides. https://app.cochat.ai/papers/10.1093/hmg/ddx427
- The paper
- Shao, W., Chen, X., Samulski, R. J., Hirsch, M. L., & Li, C. (2018). Inhibition of antigen presentation during AAV gene therapy using virus peptides. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddx427
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.